MGP (Matrix Gla Protein)

These findings demonstrate that macrophage-derived exosomal MALAT1 modulates VC via the MALAT1/miR-143-3p/MGP axis under hyperglycemic conditions. The results suggest that targeting exosomal MALAT1 may offer a novel and effective therapeutic approach for mitigating VC in metabolic disorders such as diabetes.

We established a DRRG-based prognostic model for CRC and uncovered their links to metabolic regulation, immune infiltration, and metastasis. These findings highlight DRRGs as potential biomarkers and therapeutic targets and suggest that DR-mimicking strategies may benefit CRC management.

Upregulated MGP promotes cancer cell adhesion to LN lymphatics. Thus, breast cancer cell metastasis to LNs remodels LEC subsets in human LNs and escalates MGP expression, potentially facilitating cancer cell dissemination through the lymphatic system.

P=N/A, N=37, Active, not recruiting, Tufts University | Recruiting --> Active, not recruiting | Trial completion date: Dec 2025 --> Dec 2026 | Trial primary completion date: Dec 2025 --> Apr 2026

P=N/A, N=336, Recruiting, University of California, Irvine | Trial completion date: Apr 2025 --> Nov 2025 | Trial primary completion date: Apr 2025 --> Nov 2025

Osteocalcin (OC), another vitamin K2 biomarker, was potentially protective against nonalcoholic fatty liver disease (NAFLD). This novel causality discovery highlighted the necessity for further exploration of vitamin K nutritional status as a crucial factor in the pathogenesis and potential as a predictive, diagnostic, and prognostic biomarker for disease, including carcinoma, liver disease, myocardial infarction, heart failure, and related disorders.

Despite the promising role of vitamin K, findings are mixed on its role in bone mineral density and fracture prevention, cardiovascular protection, protection against vascular calcification, diabetes prevention, cancer risk, kidney dysfunction, and its role in maternal and child health. These highlight the need for further research, particularly longitudinal and randomized controlled trials, to determine optimal intake, efficacy of supplementation, and long-term health impacts of vitamin K in women.

P=N/A, N=60, Completed, London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | Active, not recruiting --> Completed

Conversely, p65 knockdown mitigated the effects of MGP overexpression on HuCCT1 cell proliferation (P < 0.01) and CD8+ T-cell exhaustion (P < 0.01 and P < 0.001), while also significantly reducing PD-L1 expression (P < 0.01). MGP promotes CD8+ T-cell exhaustion and facilitates immune evasion in ICC through NF-κB pathway activation.

P1/2, N=55, Recruiting, Boston University | Not yet recruiting --> Recruiting

We divided the results by subsite for markers: lymph node analysis (microRNAs, myosin-5a (MYO5A), ring finger protein 145 (RNF145), F-box only protein 32 (FBXO32), CTONG2002744, cytokeratin 14 (CK14), eukaryotic initiation factor 4E (eIF4E), desmoglein-3 (DSG3), microsatellite D9S171, squamous cell carcinoma antigen, cytokeratin, tumor budding score, human papillomavirus-DNA (HPV-DNA), tumor infiltrating lymphocytes, sentinel lymph node analysis techniques, single fiber reflectance spectroscopy, radiological techniques), tumor tissue analysis (activin A, carcinoma-associated fibroblasts, cyclins, β-catenin, histopathology, genetic amplifications, DNA methylation, ecotropic viral integration site 1, CC-chemokine receptor 7, melanoma associated-A antigens, vascular endothelial growth factor-C (VEGF-C), panitumumab, epidermal growth factor receptor (EGFR), cornulin, total protein analysis, CD133, NANOG homeobox, neurogenic locus notch homolog protein 1 (NOTCH1), metastasis-associated protein 1, 14-3-3-zeta, E-cadherin, focal adhesion kinase, p-epithelial-mesenchymal transition (EMT), small proline rich protein 1B (SPRR1B), transcription factor NKX3-1, DNA copy number aberrations, microfibril-associated protein 5 (MFAP5), troponin C1, slow skeletal and cardiac type (TNNC1), matrix Gla protein (MGP), fibroblast growth factor binding protein 1 (FBFBP1), F-box protein 32 (FBXO32), fatty acid binding protein 5, B cell-specific Moloney murine leukemia virus integration site 1, podoplanin, p53, Bcl-2, epidermal growth factor receptor (EGFR), Ki67, cyclin D1, cox-2, semaphorin-3F, neuropilin-2, histologic features, cellular dissociation grade, prospero homeobox protein 1, radiologic features, Ki-67, poly (ADP-ribose) polymerase (PARP), Bcl-2 associated agonist of cell death (BAD), caspase-9, vascular endothelial growth factor A (VEGF-A), HPV, p16, methylation status of long interspersed element 1 (LINE-1) and Alu elements, mesenchymal-epithelial transition (MET), gene expression analyses, molecular subtypes) and blood markers (standard blood analysis indexes and ratios, circulating tumor cells, HPV-DNA, CD-31, bone marrow analysis). Several promising markers were identified, including miR-205, desmoglein 3 (DSG3), pan-cytokeratin (CK) AE1/AE3, HPV-16, activin-A, cyclin D1, E-cadherin, and neural progenitor lineage (NPL) that demonstrated effectiveness across multiple studies. Future research should focus on exploring combination scoring systems to improve diagnostic precision and optimize treatment selection in HNSCC patients.

Western blot and ELISA analysis on genes related to the PPAR signaling pathway showed that interfering with MGP increased the expression of proteins such as RXRα, indicating the possible activation of the PPAR signaling pathway. In summary, Beta-sitosterol may promote the differentiation of bovine preadipocytes by reducing the expression of MGP, thereby activating the PPAR signaling pathway.